by Jordana Choucair | Feb 6, 2023 | Life Sciences
A Wall Street Journal article examines how Amazon’s new RxPass prescription service and Mark Cuban’s Cost Plus Drug Co. are increasing the downward pressure on the cost of generic drugs. The competition from both entities has instigated more established players...
by Jordana Choucair | Feb 3, 2023 | Life Sciences
The Biden administration unveiled new partnerships directed at cancer care and prevention. The 13 initiatives, announced on the anniversary of the revived Cancer Moonshot, are part of the White House’s overarching effort to reduce cancer death rates and improve...
by Jordana Choucair | Feb 2, 2023 | Life Sciences
The Federal Trade Commission (FTC) fined GoodRx Holdings Inc. $1.5 million for allegedly sharing users’ health data with advertising platforms like Meta Platforms Inc.’s Facebook and Alphabet Inc.’s Google. The action is the first of its kind under...
by Jordana Choucair | Feb 2, 2023 | Life Sciences
A coalition of 20 Republican attorneys general told Walgreens Boots Alliance Inc. and CVS Health Corp. that they could face legal action if they mail and distribute abortion pills, stating in a letter that federal law prohibits using the mail to send or receive...
by Jordana Choucair | Feb 1, 2023 | Life Sciences
Food and Drug Administration (FDA) Commissioner Robert Califf proposed that the food portion of the FDA should be reorganized under a new deputy commissioner for Human Foods. Under the proposed plan, several existing centers “will be unified into a newly...
by Jordana Choucair | Jan 30, 2023 | Life Sciences
A study published in JAMA Health Forum found that a provision in the Inflation Reduction Act (Act) that allows Medicare to negotiate prices on the costliest prescription drugs each year will likely save the U.S. billions of dollars. Researchers identified 40 drugs...
Recent Comments